Advertisement
Research Article Free access | 10.1172/JCI113012
Find articles by Cannistra, S. in: JCI | PubMed | Google Scholar
Find articles by Rambaldi, A. in: JCI | PubMed | Google Scholar
Find articles by Spriggs, D. in: JCI | PubMed | Google Scholar
Find articles by Herrmann, F. in: JCI | PubMed | Google Scholar
Find articles by Kufe, D. in: JCI | PubMed | Google Scholar
Find articles by Griffin, J. in: JCI | PubMed | Google Scholar
Published June 1, 1987 - More info
Human granulocyte-macrophage colony-stimulating factor (GM-CSF) exerts profound effects on the proliferation, differentiation, and effector function of myeloid lineage cells. In contrast to its growth-promoting effects on normal myeloid progenitor cells, we found that GM-CSF unexpectedly inhibited the colony growth of U937 cells in agar culture. Furthermore, medium conditioned by recombinant GM-CSF(rGM-CSF)-treated U937 cells was found to exert an inhibitory effect on subsequent U937 colony growth that was partially due to the presence of tumor necrosis factor (TNF). By Northern blot analysis, rGM-CSF was shown to induce expression of the TNF gene in U937 cells and in T-lymphocyte-depleted, monocyte-enriched peripheral blood mononuclear cells. Furthermore, rGM-CSF was observed to significantly enhance TNF secretion by monocytes stimulated with endotoxin and phorbol myristate acetate (PMA). These data suggest that some of the biological effects of GM-CSF may be amplified through the release of monokines such as TNF.
Images.